Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists
AR Li, MG Johnson, J Liu, X Chen, X Du… - Bioorganic & medicinal …, 2008 - Elsevier
… A series of six–six and six–five fused heterocyclic CXCR3 antagonists has been synthesized
… properties that could serve as useful tools to study the role of the CXCR3 receptor in vivo. …
… properties that could serve as useful tools to study the role of the CXCR3 receptor in vivo. …
Optimization of a series of quinazolinone-derived antagonists of CXCR3
J Liu, Z Fu, AR Li, M Johnson, L Zhu, A Marcus… - Bioorganic & medicinal …, 2009 - Elsevier
… Overall, the examined heterocyclic replacements did not … the heterocyclic replacements were
not adopted for further studies. … to use the 8-azaquinazolinone core for further optimization. …
not adopted for further studies. … to use the 8-azaquinazolinone core for further optimization. …
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3
M Johnson, AR Li, J Liu, Z Fu, L Zhu, S Miao… - Bioorganic & Medicinal …, 2007 - Elsevier
A series of quinazolinone-derived inhibitors of the CXCR3 receptor have been synthesized
and their affinity for the receptor evaluated. Compounds were evaluated in a 125 I-IP10 …
and their affinity for the receptor evaluated. Compounds were evaluated in a 125 I-IP10 …
[PDF][PDF] Design, synthesis and pharmacological evaluation of non-peptidergic ligands for the human CXCR3 receptor
S Storelli - 2010 - research.vu.nl
… Classes of CXCR3 antagonists with strikingly variable core … bicyclic core for a wide
variety of heterocyclic groups (16) was … and optimization of a series of quinazolinone-derived …
variety of heterocyclic groups (16) was … and optimization of a series of quinazolinone-derived …
Design, synthesis, and pharmacological evaluation of benzimidazolo-thiazoles as potent CXCR3 antagonists with therapeutic potential in autoimmune diseases …
E Caroff, EA Meyer, P Äänismaa… - Journal of Medicinal …, 2022 - ACS Publications
… we explored the benzimidazolo-thiazole core scaffold. The … ring was replaced by smaller
heterocycles. Herein, we describe … We started our optimization program with the replacement of …
heterocycles. Herein, we describe … We started our optimization program with the replacement of …
Designing small molecule CXCR3 antagonists
JE Pease - Expert Opinion on Drug Discovery, 2017 - Taylor & Francis
… Optimization of the quinazolinone series from which AMG 487 emerged identified a lead …
Similarly, substitution at the C4-position of the azaquinazolinone core also yielded derivatives …
Similarly, substitution at the C4-position of the azaquinazolinone core also yielded derivatives …
Research progress of CXCR3 inhibitors
Z Yuan - Anti-Cancer Drugs, 2024 - journals.lww.com
… of the optimized derivative compounds have produced CXCR3 … of two high affinity CXCR3
antagonists were shown, which … nitrogen atoms in the heterocyclic scaffold of the compound …
antagonists were shown, which … nitrogen atoms in the heterocyclic scaffold of the compound …
Chemokine receptor antagonists: part 2
… Lead optimization with this strategy led to the discovery of compound 14n ( Figure 3 ,
compound 7 ) as the most potent CXCR3 antagonist on both human and mouse CXCR3 inhibiting …
compound 7 ) as the most potent CXCR3 antagonist on both human and mouse CXCR3 inhibiting …
On the value of homology models for virtual screening: discovering hCXCR3 antagonists by pharmacophore-based and structure-based approaches
… The CXCR3 antagonist activities were measured in CXCR3 mediated chemotaxis assays …
NCI compounds were docked against the optimized homology model with the MOE docking …
NCI compounds were docked against the optimized homology model with the MOE docking …